- Sareum notes GSK's completed acquisition of Sierra
- Sareum to Present at BioTrinity 2022 Conference
- Sareum notes acquisition of Sierra Oncology by GSK
- Second Price Monitoring Extn
- Price Monitoring Extension
- European Patent Granted for Sareum’s SDC-1802
- SDC-1801: Preclinical Toxicology Report Received
- Results of EGM
- Half-year Report
- Publication of Circular; Notice of General Meeting
More ▼
Key statistics
On Monday, Sareum Holdings PLC (SAR:LSE) closed at 200.10, 116.32% above the 52 week low of 92.50 set on Mar 09, 2022.
52-week range
Markit short selling activity
Open | 212.50 |
---|---|
High | 195.00 |
Low | 195.00 |
Bid | 200.00 |
Offer | 205.00 |
Previous close | 205.00 |
Average volume | 63.92k |
---|---|
Shares outstanding | 68.07m |
Free float | 63.73m |
P/E (TTM) | -- |
Market cap | 139.54m GBP |
EPS (TTM) | -0.0273 GBP |
Data delayed at least 20 minutes, as of Jul 04 2022 16:12 BST.
More ▼